These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2157776)

  • 1. Erythropoietin: receptors and clinical use in rheumatoid arthritis.
    Krantz SB; Sawyer ST; Sawada K; Wolfe F; Bocagno J
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():181-95; discussion 195-8. PubMed ID: 2157776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of recombinant human 125I-erythropoietin to CFU-E from the spleen of anemic mice.
    Vannucchi AM; Grossi A; Rafanelli D; Vannucchi L; Rossi Ferrini P
    Haematologica; 1990; 75(1):21-6. PubMed ID: 2159943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions.
    Akahane K; Tojo A; Fukamachi H; Kitamura T; Saito T; Urabe A; Takaku F
    Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding of asialoerythropoietin.
    Dong YJ; Kung C; Goldwasser E
    J Cell Biochem; 1992 Mar; 48(3):269-76. PubMed ID: 1400613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
    Taniguchi S; Dai CH; Krantz SB
    Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.
    Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F
    Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of erythroid progenitor cells and characterization of erythropoietin receptors.
    Krantz SB; Sawyer ST; Sawada KI
    Br J Cancer Suppl; 1988 Dec; 9():31-5. PubMed ID: 2855465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells.
    Sawada K; Krantz SB; Sawyer ST; Civin CI
    J Cell Physiol; 1988 Nov; 137(2):337-45. PubMed ID: 3192618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
    Takashina N; Kondo H; Kashiwazaki S
    J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
    Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and biochemistry of the erythropoietin receptor.
    Sawyer ST
    Prog Clin Biol Res; 1990; 352():145-52. PubMed ID: 2169625
    [No Abstract]   [Full Text] [Related]  

  • 13. The sensitivity of in vitro erythropoietic progenitor cells to different erythropoietin reagents during development and the role of cell death in culture.
    Zimmermann F; Rich IN
    Exp Hematol; 1996 Feb; 24(2):330-9. PubMed ID: 8641362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-modulation of high-affinity receptors for erythropoietin on murine erythroblasts by interleukin 3.
    Fraser JK; Nicholls J; Coffey C; Lin FK; Berridge MV
    Exp Hematol; 1988 Oct; 16(9):769-73. PubMed ID: 2844574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
    Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
    Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo.
    Clibon U; Bonewald L; Caro J; Roodman GD
    Exp Hematol; 1990 Jun; 18(5):438-41. PubMed ID: 2338132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.
    Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H
    Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin: biology and clinical use.
    Graber SE; Krantz SB
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):369-400. PubMed ID: 2561121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.